de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020). Reduced lung-cancer mortality with volume CT screening in a randomized trial. New England Journal of Medicine, 382(6), 503–513.
Fagundes, C. P., Shi, Q., Vaporciyan, A. A., Rice, D. C., Popat, K. U., Cleeland, C. S., & Wang, X. S. (2015). Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. Journal of Thoracic and Cardiovascular Surgery, 150(3), 613-619.e612.
Ljungqvist, O., Scott, M., & Fearon, K. C. (2017). Enhanced recovery after surgery: A review. JAMA Surgery, 152(3), 292–298.
Huang, L., Frandsen, M. N., Kehlet, H., & Petersen, R. H. (2022). Early and late readmissions after enhanced recovery thoracoscopic lobectomy. European Journal of Cardiothoracic Surgery, 62, 3.
Bao, F., Dimitrovska, N. T., Hu, S., Chu, X., & Li, W. (2020). Safety of early discharge with a chest tube after pulmonary segmentectomy. European Journal of Cardio-Thoracic Surgery, 58(3), 613–618.
Vandrevala, T., Senior, V., Spring, L., Kelliher, L., & Jones, C. (2016). “Am I really ready to go home?”: A qualitative study of patients’ experience of early discharge following an enhanced recovery programme for liver resection surgery. Supportive Care in Cancer, 24(8), 3447–3454.
Article CAS PubMed Google Scholar
Zhang, J., Su, X., Xu, W., Yu, Q., Dai, W., Wang, Y., Zhuang, X., Li, Q., Wang, X. S., & Shi, Q. (2022). Identifying patients who suffered from post-discharge cough after lung cancer surgery. Supportive Care in Cancer, 30(9), 7705–7713.
Wang, K. Y., Chang, N. W., Wu, T. H., Hsu, C. C., Lee, Y. H., & Lee, S. C. (2010). Post-discharge health care needs of patients after lung cancer resection. Journal of Clinical Nursing, 19(17–18), 2471–2480.
Lowery, A. E., Krebs, P., Coups, E. J., Feinstein, M. B., Burkhalter, J. E., Park, B. J., & Ostroff, J. S. (2014). Impact of symptom burden in post-surgical non-small cell lung cancer survivors. Supportive Care in Cancer, 22(1), 173–180.
Dai, W., Feng, W., Zhang, Y., Wang, X. S., Liu, Y., Pompili, C., Xu, W., Xie, S., Wang, Y., Liao, J., Wei, X., Xiang, R., Hu, B., Tian, B., Yang, X., Wang, X., Xiao, P., Lai, Q., Wang, X., … Shi, Q. (2022). Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: A multicenter randomized controlled trial. Journal of Clinical Oncology, 40(9), 988–996.
Article PubMed PubMed Central Google Scholar
Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims: draft guidance. (2006). Health and Quality of Life Outcomes, 4, 79.
de Bono, J., Mateo, J., Fizazi, K., Saad, F., Shore, N., Sandhu, S., Chi, K. N., Sartor, O., Agarwal, N., Olmos, D., Thiery-Vuillemin, A., Twardowski, P., Mehra, N., Goessl, C., Kang, J., Burgents, J., Wu, W., Kohlmann, A., Adelman, C. A., & Hussain, M. (2020). Olaparib for metastatic castration-resistant prostate cancer. New England Journal of Medicine, 382(22), 2091–2102.
Kallen, M. A., Yang, D., & Haas, N. (2012). A technical solution to improving palliative and hospice care. Supportive Care in Cancer, 20(1), 167–174.
Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. European Journal of Cancer, 30(5), 635–642.
Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer, 12(3), 199–220.
Article CAS PubMed Google Scholar
Mendoza, T. R., Wang, X. S., Lu, C., Palos, G. R., Liao, Z., Mobley, G. M., Kapoor, S., & Cleeland, C. S. (2011). Measuring the symptom burden of lung cancer: The validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. The Oncologist, 16(2), 217–227.
Article PubMed PubMed Central Google Scholar
Hollen, P. J., Gralla, R. J., Kris, M. G., & Potanovich, L. M. (1993). Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS). European Journal of Cancer, 29A(Suppl 1), S51-58.
Dalziel, K., Li, J., Scott, A., & Clarke, P. (2018). Accuracy of patient recall for self-reported doctor visits: Is shorter recall better? Health Economics, 27(11), 1684–1698.
Guidance for industry: Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.[8]Food and Drug Administration.pdf. (2020).
Rolstad, S., Adler, J., & Rydén, A. (2011). Response burden and questionnaire length: Is shorter better? A review and meta-analysis. Value Health, 14(8), 1101–1108.
Gabrilove, J. L., Perez, E. A., Tomita, D. K., Rossi, G., & Cleeland, C. S. (2007). Assessing symptom burden using the M.D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer, 110(7), 1629–1640.
Northouse, L. L., Mood, D. W., Schafenacker, A., Montie, J. E., Sandler, H. M., Forman, J. D., Hussain, M., Pienta, K. J., Smith, D. C., & Kershaw, T. (2007). Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer, 110(12), 2809–2818.
Bennett, A. V., Patrick, D. L., Bushnell, D. M., Chiou, C. F., & Diehr, P. (2011). Comparison of 7-day and repeated 24-h recall of type 2 diabetes. Quality of Life Research, 20(5), 769–777.
Article CAS PubMed Google Scholar
Schaffer, E. M., Basch, E. M., Schwab, G. M., & Bennett, A. V. (2021). Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer. Clinical Trials, 18(4), 408–416.
Shi, Q., Trask, P. C., Wang, X. S., Mendoza, T. R., Apraku, W. A., Malekifar, M., & Cleeland, C. S. (2010). Does recall period have an effect on cancer patients’ ratings of the severity of multiple symptoms? Journal of Pain and Symptom Management, 40(2), 191–199.
Article PubMed PubMed Central Google Scholar
28th Annual Conference of the International Society for Quality of Life Research. (2021). Quality of Life Research, 30(Suppl 1), 1–177.
El Miedany, Y., El Gaafary, M., Youssef, S., Ahmed, I., & Palmer, D. (2014). The arthritic patients’ perspective of measuring treatment efficacy: Patient Reported Experience Measures (PREMs) as a quality tool. Clinical and Experimental Rheumatology, 32(4), 547–552.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.
Article CAS PubMed Google Scholar
Kaasa, S., Bjordal, K., Aaronson, N., Moum, T., Wist, E., Hagen, S., & Kvikstad, A. (1995). The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. European Journal of Cancer, 31(13–14), 2260–2263.
Bland, J. M., & Altman, D. G. (1997). Cronbach’s alpha. BMJ, 314(7080), 572.
Article CAS PubMed PubMed Central Google Scholar
Bartko, J. J. (1966). The intraclass correlation coefficient as a measure of reliability. Psychological Reports, 19(1), 3–11.
Article CAS PubMed Google Scholar
Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Sons Ltd.
Juniper, E. F., Guyatt, G. H., & Jaeschke, R. (1996). How to develop and validate a new health-related quality of life instrument. In B. Spilker (Ed.), Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven.
Selby, D., Cascella, A., Gardiner, K., Do, R., Moravan, V., Myers, J., & Chow, E. (2010). A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. Journal of Pain and Symptom Management, 39(2), 241–249.
Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.
Article CAS PubMed Google Scholar
Xu, W., Dai, W., Gao, Z., Wang, X. S., Tang, L., Pu, Y., Yu, Q., Yu, H., Nie, Y., Zhuang, W., Qiao, G., Cleeland, C. S., & Shi, Q. (2022). Establishment of minimal clinically important improvement for patient-reported symptoms to define recovery after video-assisted thoracoscopic surgery. Annals of Surgical Oncology, 29(9), 5593–5604.
Minton, P. D., & Cohen, J. (1971). Statistical power analysis for the behavioral sciences. Journal of the American Statistical Association, 66, 334.
Boesen, V. B., Feldt-Rasmussen, U., Bjorner, J. B., Cramon, P. K., Grøenvold, M., Rasmussen, Å. K., & Watt, T. (2020). Shorter recall period for the thyroid-related patient-reported outcome measure ThyPRO did not change the accuracy as evaluated by repeated momentary measurements. Thyroid, 30(2), 185–191.
Qin, S., Nelson, L., McLeod, L., Eremenco, S., & Coons, S. J. (2019). Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: Recommendations for selecting and documenting the analytical formula. Quality of Life Research, 28(4), 1029–1033.
Yu, H., Yu, Q., Nie, Y., Xu, W., Pu, Y., Dai, W., Wei, X., & Shi, Q. (2021). Data quality of longitudinally collected patient-reported outcomes after thoracic surgery: Comparison of paper- and web-based assessments. Journal of Medical Internet Research, 23(11), e28915.
留言 (0)